The Science-Backed Foundation of TeraVitals
Pioneering neuroscience for transformative cognitive health solutions.
Our Clinical Breakthroughs
At TeraVitals, science isn't just a department; it's our DNA. We are immensely proud to have successfully completed Phase 2 clinical trials for a novel therapeutic compound aimed at reversing the effects of Alzheimer's disease. This landmark achievement positions us at the forefront of neurodegenerative research.
The Efficacy of Our Compounds: Clinical Data Highlights
The robust data from our clinical trials demonstrate significant positive outcomes. Our core compounds have shown remarkable efficacy in:
- Reducing amyloid plaques and tau tangles (key indicators of Alzheimer's).
- Improving cognitive assessment scores in participants.
- Exhibiting neuroprotective properties, slowing neuronal degeneration.
- Beyond Alzheimer's, preclinical studies and ongoing research indicate broader therapeutic potential against various forms of dementia and other medical conditions related to cognitive decline.
Detailed publications and further data will be made available soon.
From Medicine to Supplement: Bridging Research to Daily Health
The foundational insights and effective mechanisms identified in our Alzheimer's research have been carefully adapted to formulate our flagship memory supplement, TeraVitals NeuraCare. While NeuraCare is not a treatment for Alzheimer's, it leverages the understanding of brain health derived from our rigorous clinical work to support and optimize everyday cognitive function – effectively combating brain fog and enhancing memory in healthy individuals.
Our Research Philosophy
We are committed to transparency, ethical research, and continuous innovation. Our scientific advisory board comprises leading experts in neurology, pharmacology, and clinical research, ensuring that every product we develop is grounded in the latest scientific understanding and rigorous testing methods.
Explore Our Clinical Publications (Coming Soon) Learn About NeuraCare